디지털 병리학 시장 : 카테고리별, 제품별, 용도별, 최종사용자별, 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) - 동향 분석, 경쟁 상황, 예측(2019-2030년)

Global Digital Pathology Market Doubles Its Size to Touch USD 2.4 Billion by 2030

Global Digital Pathology Market is booming primarily due to the rising prevalence of chronic diseases, shortage of skilled pathologists, and an increasing demand for remote collaboration and access to digital pathology solutions.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Digital Pathology Market size by value at USD 1.1 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Digital Pathology Market size to expand at a CAGR of 12.3% reaching a value of USD 2.4 billion by 2030. The Digital Pathology Market across the regions is propelled by the rising prevalence of cancer, the demand for efficient workflows, and the need for faster diagnostics. Investments in healthcare, new product launches, and the increasing adoption of telepathology are further accelerating market growth. Digital pathology is revolutionizing healthcare by supporting drug discovery, precision medicine, and healthcare IT solutions. The COVID-19 pandemic highlighted the critical role of digital pathology in enabling remote collaboration, rapid diagnostics, and the development of new therapeutics.

Opportunity - Growing Application of Digital Pathology in Drug Development

The growing application of digital pathology in drug development process presents a significant growth opportunity for the global market. Digital pathology enhances drug discovery by facilitating data sharing across independent labs, improving collaboration, and accelerating the development of effective therapies. This technology enables pathologists and researchers to remotely access and analyze tissue samples, improving efficiency and reducing the barriers of geography, human error, and subjectivity. By enabling automated analysis, it minimizes errors and accelerates the drug development process. Additionally, digital pathology supports precision medicine by providing valuable insights into disease behavior, helping to tailor treatments to individual patients. As the volume of data grows, digital pathology's role in drug development continues to expand, offering new opportunities for advancing medical research and creating more personalized treatments.

North America Leads Global Digital Pathology Market

North America is the dominant region in Global Digital Pathology Market, driven by robust government support, significant R&D investments, and the widespread adoption of digital imaging technologies. Key market players, such as PathAI, are launching innovative solutions like AISight to further accelerate market growth. The region's strong healthcare infrastructure and focus on advanced diagnostics are key factors contributing to its market dominance.

Impact of Escalating Geopolitical Tensions on Global Digital Pathology Market

Intensifying geopolitical tensions could have a multifaceted impact on Global Digital Pathology Market. Supply chain disruptions caused by political instability can lead to shortages of essential components and increased costs. Trade restrictions and tariffs can limit access to advanced technologies and skilled labor, hindering market growth. Moreover, the increasing risk of cyberattacks can expose sensitive patient data, necessitating robust cybersecurity measures. These challenges can significantly impact the adoption of digital pathology solutions, particularly in emerging markets.

Competitive Landscape

Global Digital Pathology Market is highly fragmented, with numerous players serving the market. The key players dominating Global Digital Pathology Market include Leica Biosystems, 3DHISTECH, Hamamatsu Photonics, Ventana Medical Systems, Philips, Sakura Finetek, Olympus, PerkinElmer, Indica Labs, Visiopharm, Paige, and PathAI. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and Global Digital Pathology Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Digital Pathology Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Category Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Digital Pathology Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Rising Incidence of Chronic Diseases
    • 3.2.1.2. Shortage of Skilled Pathologists
    • 3.2.1.3. Enhanced Collaboration and Remote Access
  • 3.2.2. Restraints
    • 3.2.2.1. High Initial Investment Cost
    • 3.2.2.2. Complex Workflow Integration
  • 3.2.3. Opportunities
    • 3.2.3.1. Streamlined Workflows and Increased Efficiency
    • 3.2.3.2. Growing Application in Drug Development
  • 3.2.4. Challenges
    • 3.2.4.1. Data Security and Privacy Concerns
    • 3.2.4.2. Lack of Standardized Guidelines and Regulations
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Digital Pathology Market: Marketing Strategies

5. Global Digital Pathology Market: Pricing Analysis

6. Global Digital Pathology Market: Geographical Analysis

• 6.1. Global Digital Pathology Market, Geographical Analysis, 2023
• 6.2. Global Digital Pathology Market, Market Attractiveness Analysis, 2024-2030

7. Global Digital Pathology Market Overview

• 7.1. Market Size & Forecast, 2019-2030
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Category
    • 7.2.1.1. Human Pathology
    • 7.2.1.2. Veterinary Pathology
  • 7.2.2. By Product
    • 7.2.2.1. Scanners
    • 7.2.2.2. Software
    • 7.2.2.3. Integrated
    • 7.2.2.4. Standalone
    • 7.2.2.5. Storage Systems
    • 7.2.2.6. Others
  • 7.2.3. By Application
    • 7.2.3.1. Teleconsultation
    • 7.2.3.2. Disease Diagnosis
    • 7.2.3.3. Drug Discovery
    • 7.2.3.4. Training and Education
    • 7.2.3.5. Others
  • 7.2.4. By End User
    • 7.2.4.1. Pharmaceutical & Biotechnology Companies
    • 7.2.4.2. Hospitals and Reference Laboratories
    • 7.2.4.3. Academic & Research Institutes
    • 7.2.4.4. Others
  • 7.2.5. By Region
    • 7.2.5.1. North America
    • 7.2.5.2. Europe
    • 7.2.5.3. Asia Pacific (APAC)
    • 7.2.5.4. Latin America (LATAM)
    • 7.2.5.5. Middle East and Africa (MEA)

8. North America Digital Pathology Market

• 8.1. Market Size & Forecast, 2019-2030
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Category
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
    • 8.2.5.1. United States
    • 8.2.5.1.1. By Category
    • 8.2.5.1.2. By Product
    • 8.2.5.1.3. By Application
    • 8.2.5.1.4. By End User
    • 8.2.5.2. Canada
    • 8.2.5.2.1. By Category
    • 8.2.5.2.2. By Product
    • 8.2.5.2.3. By Application
    • 8.2.5.2.4. By End User

9. Europe Digital Pathology Market

• 9.1. Market Size & Forecast, 2019-2030
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Category
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
    • 9.2.5.1. Germany
    • 9.2.5.1.1. By Category
    • 9.2.5.1.2. By Product
    • 9.2.5.1.3. By Application
    • 9.2.5.1.4. By End User
    • 9.2.5.2. United Kingdom
    • 9.2.5.2.1. By Category
    • 9.2.5.2.2. By Product
    • 9.2.5.2.3. By Application
    • 9.2.5.2.4. By End User
    • 9.2.5.3. Italy
    • 9.2.5.3.1. By Category
    • 9.2.5.3.2. By Product
    • 9.2.5.3.3. By Application
    • 9.2.5.3.4. By End User
    • 9.2.5.4. France
    • 9.2.5.4.1. By Category
    • 9.2.5.4.2. By Product
    • 9.2.5.4.3. By Application
    • 9.2.5.4.4. By End User
    • 9.2.5.5. Spain
    • 9.2.5.5.1. By Category
    • 9.2.5.5.2. By Product
    • 9.2.5.5.3. By Application
    • 9.2.5.5.4. By End User
    • 9.2.5.6. Belgium
    • 9.2.5.6.1. By Category
    • 9.2.5.6.2. By Product
    • 9.2.5.6.3. By Application
    • 9.2.5.6.4. By End User
    • 9.2.5.7. Russia
    • 9.2.5.7.1. By Category
    • 9.2.5.7.2. By Product
    • 9.2.5.7.3. By Application
    • 9.2.5.7.4. By End User
    • 9.2.5.8. The Netherlands
    • 9.2.5.8.1. By Category
    • 9.2.5.8.2. By Product
    • 9.2.5.8.3. By Application
    • 9.2.5.8.4. By End User
    • 9.2.5.9. Rest of Europe
    • 9.2.5.9.1. By Category
    • 9.2.5.9.2. By Product
    • 9.2.5.9.3. By Application
    • 9.2.5.9.4. By End User

10. Asia Pacific Digital Pathology Market

• 10.1. Market Size & Forecast, 2019-2030
  • 10.1.1. By Value (USD Billion)
• 10.2. Market Share & Forecast
  • 10.2.1. By Category
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
    • 10.2.5.1. China
    • 10.2.5.1.1. By Category
    • 10.2.5.1.2. By Product
    • 10.2.5.1.3. By Application
    • 10.2.5.1.4. By End User
    • 10.2.5.2. India
    • 10.2.5.2.1. By Category
    • 10.2.5.2.2. By Product
    • 10.2.5.2.3. By Application
    • 10.2.5.2.4. By End User
    • 10.2.5.3. Japan
    • 10.2.5.3.1. By Category
    • 10.2.5.3.2. By Product
    • 10.2.5.3.3. By Application
    • 10.2.5.3.4. By End User
    • 10.2.5.4. South Korea
    • 10.2.5.4.1. By Category
    • 10.2.5.4.2. By Product
    • 10.2.5.4.3. By Application
    • 10.2.5.4.4. By End User
    • 10.2.5.5. Australia & New Zealand
    • 10.2.5.5.1. By Category
    • 10.2.5.5.2. By Product
    • 10.2.5.5.3. By Application
    • 10.2.5.5.4. By End User
    • 10.2.5.6. Indonesia
    • 10.2.5.6.1. By Category
    • 10.2.5.6.2. By Product
    • 10.2.5.6.3. By Application
    • 10.2.5.6.4. By End User
    • 10.2.5.7. Malaysia
    • 10.2.5.7.1. By Category
    • 10.2.5.7.2. By Product
    • 10.2.5.7.3. By Application
    • 10.2.5.7.4. By End User
    • 10.2.5.8. Singapore
    • 10.2.5.8.1. By Category
    • 10.2.5.8.2. By Product
    • 10.2.5.8.3. By Application
    • 10.2.5.8.4. By End User
    • 10.2.5.9. Vietnam
    • 10.2.5.9.1. By Category
    • 10.2.5.9.2. By Product
    • 10.2.5.9.3. By Application
    • 10.2.5.9.4. By End User
    • 10.2.5.10. Rest of APAC
    • 10.2.5.10.1. By Category
    • 10.2.5.10.2. By Product
    • 10.2.5.10.3. By Application
    • 10.2.5.10.4. By End User

11. Latin America Digital Pathology Market

• 11.1. Market Size & Forecast, 2019-2030
  • 11.1.1. By Value (USD Billion)
• 11.2. Market Share & Forecast
  • 11.2.1. By Category
  • 11.2.2. By Product
  • 11.2.3. By Application
  • 11.2.4. By End User
  • 11.2.5. By Country
    • 11.2.5.1. Brazil
    • 11.2.5.1.1. By Category
    • 11.2.5.1.2. By Product
    • 11.2.5.1.3. By Application
    • 11.2.5.1.4. By End User
    • 11.2.5.2. Mexico
    • 11.2.5.2.1. By Category
    • 11.2.5.2.2. By Product
    • 11.2.5.2.3. By Application
    • 11.2.5.2.4. By End User
    • 11.2.5.3. Argentina
    • 11.2.5.3.1. By Category
    • 11.2.5.3.2. By Product
    • 11.2.5.3.3. By Application
    • 11.2.5.3.4. By End User
    • 11.2.5.4. Peru
    • 11.2.5.4.1. By Category
    • 11.2.5.4.2. By Product
    • 11.2.5.4.3. By Application
    • 11.2.5.4.4. By End User
    • 11.2.5.5. Rest of LATAM
    • 11.2.5.5.1. By Category
    • 11.2.5.5.2. By Product
    • 11.2.5.5.3. By Application
    • 11.2.5.5.4. By End User

12. Middle East & Africa Digital Pathology Market

• 12.1. Market Size & Forecast, 2019-2030
  • 12.1.1. By Value (USD Billion)
• 12.2. Market Share & Forecast
  • 12.2.1. By Category
  • 12.2.2. By Product
  • 12.2.3. By Application
  • 12.2.4. By End User
  • 12.2.5. By Country
    • 12.2.5.1. Saudi Arabia
    • 12.2.5.1.1. By Category
    • 12.2.5.1.2. By Product
    • 12.2.5.1.3. By Application
    • 12.2.5.1.4. By End User
    • 12.2.5.2. UAE
    • 12.2.5.2.1. By Category
    • 12.2.5.2.2. By Product
    • 12.2.5.2.3. By Application
    • 12.2.5.2.4. By End User
    • 12.2.5.3. Qatar
    • 12.2.5.3.1. By Category
    • 12.2.5.3.2. By Product
    • 12.2.5.3.3. By Application
    • 12.2.5.3.4. By End User
    • 12.2.5.4. Kuwait
    • 12.2.5.4.1. By Category
    • 12.2.5.4.2. By Product
    • 12.2.5.4.3. By Application
    • 12.2.5.4.4. By End User
    • 12.2.5.5. South Africa
    • 12.2.5.5.1. By Category
    • 12.2.5.5.2. By Product
    • 12.2.5.5.3. By Application
    • 12.2.5.5.4. By End User
    • 12.2.5.6. Nigeria
    • 12.2.5.6.1. By Category
    • 12.2.5.6.2. By Product
    • 12.2.5.6.3. By Application
    • 12.2.5.6.4. By End User
    • 12.2.5.7. Algeria
    • 12.2.5.7.1. By Category
    • 12.2.5.7.2. By Product
    • 12.2.5.7.3. By Application
    • 12.2.5.7.4. By End User
    • 12.2.5.8. Rest of MEA
    • 12.2.5.8.1. By Category
    • 12.2.5.8.2. By Product
    • 12.2.5.8.3. By Application
    • 12.2.5.8.4. By End User

13. Competitive Landscape

• 13.1. List of Key Players and Their Category
• 13.2. Global Digital Pathology Company Market Share Analysis, 2023
• 13.3. Competitive Benchmarking, By Operating Parameters
• 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Digital Pathology Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

• 15.1. Leica Biosystems
• 15.2. 3DHISTECH
• 15.3. Hamamatsu Photonics
• 15.4. Ventana Medical Systems
• 15.5. Philips
• 15.6. Sakura Finetek
• 15.7. Olympus
• 15.8. PerkinElmer
• 15.9. Indica Labs
• 15.10. Visiopharm
• 15.11. Paige
• 15.12. PathAI
• 15.13. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

• 17.1. Qualitative Research
  • 17.1.1. Primary & Secondary Research
• 17.2. Quantitative Research
• 17.3. Market Breakdown & Data Triangulation
  • 17.3.1. Secondary Research
  • 17.3.2. Primary Research
• 17.4. Breakdown of Primary Research Respondents, By Region
• 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable